Health
New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2 – News-Medical.Net
In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-C…
In a groundbreaking bioRxiv* study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.
In response to the ongoing health crisis brought by th…
-
Noosa News21 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News21 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News